179 related articles for article (PubMed ID: 31540114)
1. FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.
Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
[TBL] [Abstract][Full Text] [Related]
2. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
4. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Hibi M; Kaneda H; Tanizaki J; Sakai K; Togashi Y; Terashima M; De Velasco MA; Fujita Y; Banno E; Nakamura Y; Takeda M; Ito A; Mitsudomi T; Nakagawa K; Okamoto I; Nishio K
Cancer Sci; 2016 Nov; 107(11):1667-1676. PubMed ID: 27581340
[TBL] [Abstract][Full Text] [Related]
5. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455.
Darwis NDM; Horigome E; Li S; Adachi A; Oike T; Shibata A; Hirota Y; Ohno T
Cells; 2022 May; 11(11):. PubMed ID: 35681425
[TBL] [Abstract][Full Text] [Related]
7. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
[TBL] [Abstract][Full Text] [Related]
9. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
Jeong J; Taasti VT; Jackson A; Deasy JO
Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
[TBL] [Abstract][Full Text] [Related]
10. Secondary cancers after carbon-ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study.
Nitta Y; Murata H; Okonogi N; Murata K; Wakatsuki M; Karasawa K; Kato S; Yamada S; Nakano T; Tsuji H
Cancer Med; 2022 Jun; 11(12):2445-2454. PubMed ID: 35318825
[TBL] [Abstract][Full Text] [Related]
11.
Fang X; Sun P; Dong Y; Huang Y; Lu JJ; Kong L
Front Oncol; 2023; 13():896142. PubMed ID: 37081974
[TBL] [Abstract][Full Text] [Related]
12. Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer.
Mizobuchi T; Yamamoto N; Nakajima M; Baba M; Miyoshi K; Nakayama H; Watanabe S; Katoh R; Kohno T; Kamiyoshihara M; Nishio W; Kamada T; Fujisawa T; Yoshino I
Eur J Cardiothorac Surg; 2016 May; 49(5):1503-9. PubMed ID: 26468271
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the role of carbon ion radiation therapy in recurrent rectal cancer.
Venkatesulu BP; Giridhar P; Malouf TD; Trifletti DM; Krishnan S
Acta Oncol; 2020 Oct; 59(10):1218-1223. PubMed ID: 32476538
[TBL] [Abstract][Full Text] [Related]
14. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma.
Byun HK; Kim C; Seong J
Clin Mol Hepatol; 2023 Oct; 29(4):945-957. PubMed ID: 37583055
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455.
Wu D; Guo M; Philips MA; Qu L; Jiang L; Li J; Chen X; Chen Z; Chen L; Chen Y
PLoS One; 2016; 11(9):e0162491. PubMed ID: 27618313
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance.
Dehghanian F; Alavi S
Sci Rep; 2021 Aug; 11(1):16593. PubMed ID: 34400727
[TBL] [Abstract][Full Text] [Related]
17. Development of a Vaginal Immobilization Device: A Treatment-planning Study of Carbon-ion Radiotherapy and Intensity-modulated Radiation Therapy for Uterine Cervical Cancer.
Kubota Y; Ohno T; Kawashima M; Murata K; Okonogi N; Noda SE; Tsuda K; Sakai M; Tashiro M; Nakano T
Anticancer Res; 2019 Apr; 39(4):1915-1921. PubMed ID: 30952733
[TBL] [Abstract][Full Text] [Related]
18. Carbon-Ion Radiation Therapy for Unresectable Locally Recurrent Colorectal Cancer: A Promising Curative Treatment for Both Radiation Therapy: Naïve Cases and Reirradiation Cases.
Takiyama H; Yamada S; Isozaki T; Ikawa H; Shinoto M; Imai R; Koto M
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):734-742. PubMed ID: 37776980
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
Okonogi N; Wakatsuki M; Kato S; Shiba S; Kobayashi D; Kiyohara H; Karasawa K; Ohno T; Nakano T; Kamada T; Shozu M;
Anticancer Res; 2018 Jan; 38(1):457-463. PubMed ID: 29277809
[TBL] [Abstract][Full Text] [Related]
20. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]